146 related articles for article (PubMed ID: 35118633)
1. Impact of transforming growth factor beta 1 on normal and thyroid cancer side population cells.
Latar NM; Mahkamova K; Elson J; Karnik I; Sutherland R; Aspinall S; Meeson A
Endocrine; 2022 May; 76(2):359-368. PubMed ID: 35118633
[TBL] [Abstract][Full Text] [Related]
2. Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma.
Matoba H; Sugano S; Yamaguchi N; Miyachi Y
Horm Metab Res; 1998 Oct; 30(10):624-8. PubMed ID: 9851670
[TBL] [Abstract][Full Text] [Related]
3. Notch and TGF-β/Smad3 pathways are involved in the interaction between cancer cells and cancer-associated fibroblasts in papillary thyroid carcinoma.
Zhang J; Wang Y; Li D; Jing S
Tumour Biol; 2014 Jan; 35(1):379-85. PubMed ID: 23918305
[TBL] [Abstract][Full Text] [Related]
4. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of Rap1GAP Expression Activates the TGF-
Yan Z; Yangyanqiu W; Shuwen H; Jing M; Haihong L; Gong C; Yin J; Qing Z; Weili G
Biomed Res Int; 2021; 2021():6840642. PubMed ID: 34840979
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells.
Cui M; Chang Y; Du W; Liu S; Qi J; Luo R; Luo S
Med Sci Monit; 2018 Jul; 24():5152-5158. PubMed ID: 30042377
[TBL] [Abstract][Full Text] [Related]
7. Transforming Growth Factor β1 Could Influence Thyroid Nodule Elasticity and Also Improve Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Li Y; Wang Y; Wu Q; Hu B
Ultrasound Med Biol; 2015 Nov; 41(11):2866-72. PubMed ID: 26306431
[TBL] [Abstract][Full Text] [Related]
8. FoxP3 in papillary thyroid carcinoma induces NIS repression through activation of the TGF-β1/Smad signaling pathway.
Ma S; Wang Q; Ma X; Wu L; Guo F; Ji H; Liu F; Zhao Y; Qin G
Tumour Biol; 2016 Jan; 37(1):989-98. PubMed ID: 26264613
[TBL] [Abstract][Full Text] [Related]
9. Expression of TGF-β1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma.
Wang N; Jiang R; Yang JY; Tang C; Yang L; Xu M; Jiang QF; Liu ZM
J Mol Histol; 2014 Aug; 45(4):391-9. PubMed ID: 24276590
[TBL] [Abstract][Full Text] [Related]
10. Mutual regulation of TGF-β1, TβRII and ErbB receptors expression in human thyroid carcinomas.
Mincione G; Tarantelli C; Vianale G; Di Marcantonio MC; Cotellese R; Francomano F; Di Nicola M; Costantini E; Cichella A; Muraro R
Exp Cell Res; 2014 Sep; 327(1):24-36. PubMed ID: 24973511
[TBL] [Abstract][Full Text] [Related]
11. [The clinicopathological associations between TGF-β1 and papillary thyroid carcinoma: a Meta-analysis.].
Xu Y; Ma L; Zhang GA; Wang W; Zhang RY; Hou S; Cui W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep; 31(18):1431-1435. PubMed ID: 29798000
[No Abstract] [Full Text] [Related]
12. Differential expression of transforming growth factor-beta in benign vs. papillary thyroid cancer nodules; a potential diagnostic tool?
Brace MD; Wang J; Petten M; Bullock MJ; Makki F; Trites J; Taylor SM; Hart RD
J Otolaryngol Head Neck Surg; 2014 Jul; 43(1):22. PubMed ID: 25927212
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
Matsuo SE; Leoni SG; Colquhoun A; Kimura ET
J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618
[TBL] [Abstract][Full Text] [Related]
14. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
[TBL] [Abstract][Full Text] [Related]
15. Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/Smad2/3 signaling pathway in papillary thyroid carcinoma.
Min WP; Wei XF
Auris Nasus Larynx; 2021 Jun; 48(3):487-495. PubMed ID: 33077306
[TBL] [Abstract][Full Text] [Related]
16. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
[TBL] [Abstract][Full Text] [Related]
17. Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer.
Garcia-Rendueles AR; Rodrigues JS; Garcia-Rendueles ME; Suarez-Fariña M; Perez-Romero S; Barreiro F; Bernabeu I; Rodriguez-Garcia J; Fugazzola L; Sakai T; Liu F; Cameselle-Teijeiro J; Bravo SB; Alvarez CV
Oncogene; 2017 Feb; 36(5):652-666. PubMed ID: 27452523
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA ANRIL promotes the invasion and metastasis of thyroid cancer cells through TGF-β/Smad signaling pathway.
Zhao JJ; Hao S; Wang LL; Hu CY; Zhang S; Guo LJ; Zhang G; Gao B; Jiang Y; Tian WG; Luo DL
Oncotarget; 2016 Sep; 7(36):57903-57918. PubMed ID: 27507052
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of TGF-beta1 on telomerase activity in thyroid carcinoma cell lines.
Lindkvist A; Franzén A; Ren ZP; Heldin NE; Paulsson-Karlsson Y
Biochem Biophys Res Commun; 2005 Dec; 338(3):1625-33. PubMed ID: 16288728
[TBL] [Abstract][Full Text] [Related]
20. Dynamic balance of multiple myeloma clonogenic side population cell percentages controlled by environmental conditions.
Wen J; Tao W; Kuiatse I; Lin P; Feng Y; Jones RJ; Orlowski RZ; Zu Y
Int J Cancer; 2015 Mar; 136(5):991-1002. PubMed ID: 25042852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]